Gastroenterology News

MADRID — Remarkable. Highly meaningful. Monumental.

The Residency to Retirement resource center offers insightful and innovative strategies to help physicians reduce taxes, protect assets, invest wisely and build wealth during all phases of their careers.

Throughout 2023, gastroenterology societies made several significant clinical practice updates to guide diagnosis, management and treatment of various GI disorders such as celiac disease, inflammatory bowel disease and acute liver failure.

Disparities and lack of equitable care in gastroenterology and health care as a whole impact job satisfaction, retention and education for providers as well as patient access to care and feeling of acceptance among patients.

From updates in colorectal cancer screening to developments in screening methods, Healio has been at the forefront of coverage for gastrointestinal cancer in 2023 – but has the important news made its way to your patients?

In the second half of 2023, there were numerous landmark FDA approvals for gastroenterology and hepatology, in particular for the treatment of ulcerative colitis, with four new options squeezing into an already saturated market.

The FDA in 2023 approved treatments for several hospital-associated infections and fully approved a long-used COVID-19 medication, among other non-vaccine-related regulatory decisions.

BOSTON — Use of directly observed therapy was successful even at extended intervals when treating hepatitis C virus infection among people who inject drugs, according to research presented at The Liver Meeting.

Women who underwent bariatric surgery gained less weight during pregnancy compared with matched controls, and weight gain was lower in those who conceived shortly after surgery, according to data in JAMA Network Open.

BOSTON — A regimen of sofosbuvir/velpatasvir with ribavirin was effective among patients with refractory chronic hepatitis C virus with liver cirrhosis and chronic kidney disease, according to data presented at The Liver Meeting.